Remdesivir Intermediate CAS 946511-97-3 COVID-19 (S)-2-Ethylbutyl 2-Aminopropanoate Hydrochloride

Short Description:

Name: (S)-2-Ethylbutyl 2-Aminopropanoate Hydrochloride

Synonyms: L-Alanine 2-Ethylbutyl Ester Hydrochloride 

CAS: 946511-97-3

Appearance: White to Almost White Powder Purity: ≥99.0%

Intermediate of Remdesivir (CAS 1809249-37-3) for the treatment of COVID-19

High Quality, Commercial Production

Inquiry: alvin@ruifuchem.com


Product Detail

Related Products

Product Tags

Description:

Chemical Properties:

Chemical Name (S)-2-Ethylbutyl 2-Aminopropanoate Hydrochloride
Synonyms Remdesivir Intermediate; L-Alanine 2-Ethylbutyl Ester Hydrochloride; Remdesivir Amino Ester Compound; Remdesivir Related Compound 8; Remdesivir Impurity 8
CAS Number 946511-97-3
CAT Number RF-PI298
Stock Status In Stock, Production Scale Up to Hundreds of Kilograms
Molecular Formula C9H20ClNO2
Molecular Weight 209.71
Melting Point 75.0 to 79.0℃
Sensitive Hygroscopic
Brand Ruifu Chemical

Specifications:

Item Specifications
Appearance White to Almost White Powder 
Loss on Drying ≤1.0%
Single Impurity ≤0.50%
Total Impurities ≤1.0%
Heavy Metals ≤20ppm
Purity ≥99.0% 
Test Standard Enterprise Standard
Usage Intermediate of Remdesivir (CAS 1809249-37-3); COVID-19

Package & Storage:

Package: Bottle, Aluminum foil bag, Cardboard drum, 25kg/Drum, or according to customer's requirement.

Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.

Advantages:

1

FAQ:

Application:

Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of (S)-2-Ethylbutyl 2-Aminopropanoate Hydrochloride (CAS 946511-97-3), it's typically used for the preparation of Remdesivir (CAS 1809249-37-3). Remdesivir, also known as GS-5734, is a novel antiviral drug in the class of nucleotide analogs developed by Gilead Sciences, with effective antiviral activity( EC50s of 74 nM for SARS-CoV and MERS-CoV in HAE cells). In February 2020 Remdesivir was being studied for experimental treatment of the emergent COVID-19 (novel coronavirus) disease.

  • Write your message here and send it to us